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Potassium carbonate in poly (ethylene glycol-400) has been found to be a highly effective and efficient medium for the 
straight forward, convenient, one pot and green synthesis of ethyl 2-substituted phenyl-7-oxo-7H-[1,3,4]- thiadiazolo [3,2-
a]- pyrimidine-6-corboxylate and -6-corbonitrile through intramolecular cyclo-elimination of Michael adducts formed 
between the reaction of 2-amino-5 substituted thiadiazoles with diethyl-2- (ethoxymethylene) malonate and ethyl-2- cyano-
3-ethoxyacrylate respectively. The structures of all the new compounds have been elucidated using IR, 1H and 13C NMR, 
mass spectral data and elemental analyses. 
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Michael addition of nucleophiles to electron deficient 
alkenes is one of the most powerful and widely used 
synthetic tools for the formation of carbon-carbon and 
carbon-hetero bonds in organic chemistry1-4. Hetero 
Michael additions, viz. aza-Michael, thia-Michael, etc. 
are the most exploited organic reactions and are the 
mainstay of efficient synthetic tools for the 
construction of druggable heterocyclic scaffolds and 
natural products5-7. Construction of molecular 
architecture by two or more bond formation in one-
step operation via Michael reaction has been one of 
the current interest in synthetic organic chemistry8, 9. 
Although reports on double Michael additions with 
cyclic and acyclic acrylates and enones are numerous, 
but with acrylates having electron withdrawing group 
at -carbon along with an ethoxy group at -carbon 
with heterocyclic amines are scare. The continual 
upsurge in facile, convenient and nonpolluting 
synthetic procedure urges chemists to increase tools 
of their arsenal. The growing awareness of the 
pressing need for greener and more sustainable 
technologies has focus attention on the use of 
alternative reaction media that circumvent the 
problems associated with traditional volatile organic 
solvents. One such approach to address this challenge 
is the elimination or reduction of the threat of use of 
volatile organic solvents to achieve the most 
important goal of green chemistry. Poly (ethylene 
glycol), a biologically acceptable polymer used in 
drug delivery has been emerged as an alternative and 
interesting green reaction media in organic synthesis. 
It has replaced many other neoteric solvents such as 
ionic liquid, super-carbon dioxide and micellar 
systems whose toxicological properties and 
biodegradability have not been established 
completely. Its unique properties such as thermal 
stability, cost effectiveness, commercial availability, 
non-volatility, reduced toxicity, ease of recyclability, 
non-halogenated nature and high polarity for 
solubilization with wide variety of organic solvents 
render PEG a designer solvent in organic synthesis. 
Although Michael addition reactions in various 
solvents have been accomplished but only few reports 
in PEG are currently known10-12. There have been 
reports on Michael addition reactions, catalysed by an 
in-expensive commercial compound, K2CO3 in 
various solvents13-16, but in PEG are scare10. 
The high therapeutic properties of the compounds 
incorporating nitrogen heterocycles have encouraged 
the medicinal chemists to synthesize large number of 
novel therapeutic agents. Thiadiazole and pyrimidine 
rings containing only nitrogen atom, are the active 
cores of various bio-active molecules. Therefore, the 
heterocyclic system resulting from the annulations of 




pyrimidine ring with bio-active thiadiazole is an 
attractive scaffold. 1,3,4-Thiadiazoles are a class of 
heterocycles which have attracted significant interest 
in medicinal chemistry and they have a wide range of 
pharmaceutical and biological activities including 
antibacterial17-21 antifungal22-25, antitubercular26,27, 
analgesic28, and leishmaniadal29 agents. Pyrimidines 
represent one of the most active classes of compounds, 
possessing a wide spectrum of biological activity30. 
Pyrimidines and their fused ring derivatives have a 
broad spectrum of biological activity, best known as 
heterocylic core of the nucleic acid bases. These ring 
systems are often incorporated into drugs designed for 
analgesic and anti-inflammatory30  ,anticancer 31, 
antiviral 32and  antihypertensive 33activites. The cyano 
group is a stable and useful functional group that can 
be transformed to various other functional groups such 
as acyl, carboxy, formyl, carbamoyl, etc31-34. The past 
seven decades has witnessed the transition of organic 
nitriles from a position of laboratory curiosities to that 
of large tonnage chemicals of commercial importance. 
On the other hand, reactions involving C-C bond 
formation are one of the mainstays in synthetic organic 
chemistry. The use of nitrile for C-C bond formation 
reactions occupies an important position in organic 
chemistry35-37. 
In the light of the above literature facts and 
abundance we report herein, an eco-benign and one-
pot aza-Michael annulations of a functionalized 
pyrimidine on thiadiazole and using potassium 
carbonate an effective and efficient catalyst 
(Scheme I). A plausible mechanism for the formation 
of titled 1,3,4- thiadiazole – [3,2-a] pyrimidine 
scaffold is given in Scheme II. The nitrogen atom at 
position -3 i.e. -NH (sp3) of 1,3,4- thiadiazole is more 
nucleophilic than = NH (sp2). Therefore, the Michael 
addition is initiated through –NH and not with =NH. 
The titled compounds by virtue of having 
functionalized pyrimidine on thiadiazole in a single 
molecule may show pronounced biocidal activity. The 
 
 
Scheme — I 




structures of these compounds was established  
by the IR,1H NMR, 13C NMR and elemental  
analysis. 
The required starting material 2-amino-5-
substituted aryl-1,3,4 thiadiazoles was prepared by 
following known method38,21. The appropriate 
thiosemicarbazide was treated with Conc. H2SO4 
dropwise. The resultant paste-like mass so obtained 
was cooled and poured in to cold water. In 
neutralisation with ammonia, solid product was 
obtained, which was filtered, washed and 
recrystallised from aqueous ethanol to furnish the 
corresponding thzadiazole derivatives. 
 
Antimicrobial Activity 
The antimicrobial activity of synthesized 
compounds 3a-d and 4a-c was determined in vitro 
against four bacterial strains. For this study, the test 
cultures of bacterial strains Escherichia coli, 
Salmonella typhii, Bacillus subtilis and 
Staphylococcus aureus were maintained in nutrient 
agar slants at 37ºC. The antimicrobial activity of 
compounds against test bacteria was determined by 
agar well diffusion method39,40 using standard 
antibiotic ciprofloxacin as positive control and DMSO 
as negative control. All the experiments were 
performed in triplicate. 
The results of present investigation showed that 
compounds 3a, 3b, 3d, 4c have promising activity 
against all the test organisms. Except 3c all the 
compounds showed moderate to good activity against 
staphylococcus aureus. Most of the other compounds 
were either active or inactive against test organisms. 
Compounds 3a, 3b and 4c is found to be most 
effective against all test organisms (Table I). 
 
Fungicidal Activity 
In vitro antifungal activity of all compounds were 
studied against two fungal strains, Candida albicans 
and Aspergillus niger. Itraconazole was employed  
as standard to compare the results. Among  
all the compounds, compound 3d and 4c has good 
antifungal activity. Compounds 3a, 3b and 4a 
displayed moderate antifungal activity and the 




All the melting points were determined on a  
Cintex melting point apparatus and are uncorrected. 
All reagents were purchased commercially and  
used without further purification. IR spectra  


















































Table I — Zone of inhibition in mm at concentration 100 ug/mL
Compd B. subtilis  S. aureus  E.coli S. typhi  
3a 32 23 28 27 
3b 24 19 23 23 
3c - 12 - - 
3d 21 20 11 - 
4a 10 12 12 - 
4b 10 17 11 - 
4c 25 21 22 19 
Ciprofloxacin 35 46 40 39 




BX series FT-IR spectrophotometer. The  
1H NMR spectra were recorded in CDCl3/DMSO-d6 
on a Varian Gemini 300 MHz spectrometer. The 
13C NMR spectra were recorded in CDCl3/DMSO-d6 
on a Jeol JNM spectrometer at 75.5 MHz. Chemical 
shifts are reported in δ (ppm) using TMS as internal 
standard. Mass spectral measurements were carried 
out at 70 eV by EI method on a Jeol JMC-300 
spectrometer. The homogeneity of the compounds 
was checked by TLC (silica gel, hexane/ethyl 
acetate). 
 
General procedure for synthesis of ethyl 2-(4-
substituted phenyl)-7-oxo-7H-[1,3,4] – thiadiazolo – [3, 
2-a]-pyrimidine-6-carboxylates, 3a-d 
To a mixture of diethyl ethoxyethylene malonate 
(2.0 mmol) and K2CO3 (0.15 mmol) in polyethylene 
glycol (5 mL) was added 2-amino-5-substituted 
phenyl-1,3,4-thiadiazole (2.0 mmol) and reaction 
mixture was allowed stir at 60ºC for 2-3 h. The 
progress of the reaction was monitored by TLC. After 
completion of the reaction, the mixture was diluted 
with water and neutralized with 1N HCl. The 
precipitate thus formed was filtered to give the 
product. The crude products 3a-d was purified  
by column chromatography and characterized  




thiadiazolo- [3,2-a]-pyrimidine-6-carboxylate, 3a: 
Colourless solid. Yield 70%. m.p.190ºC. IR: 3050  
(C-H arom), 1710 (C=O), 1675 cm−1 (C=O of 
pyrimidine ring); 1H NMR (DMSO-d6): δ 7.75-7.58  
(dd, 4H, arom), 6.7 (s,1H, pyrimidine ring proton), 4.20 
(q, J = 7Hz, 2H,OCH2), 1.25 (t, J = 7Hz,3H, CH3); 
13C NMR: δ 14.2, 61.3, 113.1,128.5, 128.9, 129.6, 136.7, 




-pyrimidine-6-carboxylate, 3b: Brown solid. Yield 
65%. m.p.205ºC. IR: 3020 (C-H arom), 1705 (C=O), 
1680 cm−1 (C=O of pyrimidine ring); 1H NMR 
(DMSO-d6): δ 7.64-7.25 (dd, 4H, arom), 6.7 (s,1H, 
pyrimidine ring proton), 4.20 (q, J = 7Hz, 2H,OCH2), 
1.25 (t, J = 7Hz,3H, CH3); 
13C NMR: δ 14.2, 21.3, 
61.6, 113.2,127.5, 129.6, 143.3, 156.0, 156.5, 163.1, 
163.7, 168.0; MS: m/z (M+) 315 (100%). 
 
Ethyl-2-(2,4-chlorophenyl)-7-oxo-7H-[1,3,4]-
thiadia zolo-[3,2-a]-pyrimidine-6-carboxylate, 3C: 
Light yellow solid. Yield 72%. m.p.180ºC. IR: 3055 
(C-H arom), 1722 (C=O), 1690 cm−1 (C=O of 
pyrimidine ring); 1H NMR (DMSO-d6): δ 7.68-7.35 
(m, 3H, arom), 6.7 (s,1H, pyrimidine ring proton), 
4.20 (q, J = 7Hz, 2H,OCH2), 1.25 (t, J = 7Hz,3H, 
CH3); 
13C NMR (CDCl3): δ 14.2, 61.3, 113.1, 127.2, 
128.7, 129.6, 132.2 135.7, 143.5, 156.1, 163.0, 163.7, 
168; MS: m/z (M+) 368.97 (100%). 
 
Ethyl 2-(4-nitrophenyl)-7-oxo-7H-[1,3,4]-thiadia 
zolo-[3,2-a]-pyrimidine-6-carboxylate, 3d: Yellow 
solid. Yield 67%. m.p.186ºC. IR: 3050 (C-H arom), 
1710 (C=O), 1685 cm−1 (C=O of pyrimidine ring); 
1H NMR (DMSO-d6): δ 8.30-8.06 (m, 4H, arom), 6.7 
(s,1H, pyrimidine ring proton), 4.20 (q, J = 7Hz, 
2H,OCH2), 1.27 (t, J = 7Hz,3H, CH3); 
13C NMR: δ 
14.2, 61.4, 113.1, 124.2, 130.4, 136.7, 143.5, 150.1, 
156.5, 163.0, 163.7, 168.5; MS: m/z (M+) 346.04 
(100%). 
 
General procedure for synthesis of 2-(substituted 
phenyl)-7-oxo-7H-[1,3,4]-thiadiazolo-[3,2-a]-pyrimidine- 
6-carbonitriles, 4a-C 
To a mixure of ethyl-2-cyano-3-ethoxy acrylate 
(2.0 mmol) and K2CO3 (0.15 mmol) in polyethylene 
glycol (5 mL) was added 2-amino-5-substituted 
phenyl-1,3,4 – thiadiazole (2.0 mmol) and reaction 
mixture was allowed stir at 60°C. The progress of the 
reaction was monitored by TLC. After completion of 
the reaction, the mixture was diluted with water and 
neutralized with 1N HCl. The precipitate thus formed 
was filtered to give the product. The crude products 
4a-c were purified by coloumn chromatography and 
characterized by 1H and 13C NMR, mass spectral data, 
and elemental analysis. 
 
2-(2-Chlorophenyl)-7-oxo-7H-[1,3,4]-thiadiazolo-
[3, 2-a]-pyrimidine-6-carbonitrile, 4a: Light brown 
solid. Yield 60%. m.p.156ºC. IR: 3015 (C-H arom), 
2205 (C≡N streching), 1682 cm−1 (C=O of pyrimidine 
ring); 1H NMR (DMSO-d6): δ 7.70-7.45 (m, 4H, 
Table II — Antifungal activity of compounds 3a-b and 4a-c 
Compd Fungal species and MIC (Ug/M2) 
 C. albicans  A. niger  
3a 5 7 
3b 8 10 
3c 0 0 
3d 17 19 
4a 8 10 
4b 0 0 
4c 16 18 
Itraconazole  24 26 
Control - - 




arom), 6.5 (s,1H, pyrimidine ring proton); 13C NMR: 
δ 99.6, 114.0, 126.8, 130.3, 130.9, 131.5, 132.4, 




o [3,2-a]pyrimidine-6-carbonitrile, 4b: Brown solid. 
Yield 65%. m.p.174ºC. IR: 3005 (C-H arom), 2219 
(C≡N streching), 1693 cm−1 (C=O of pyrimidine 
ring); 1H NMR (DMSO-d6): δ 7.68-7.47 (m, 3H, 
arom), 6.5 (s,1H, pyrimidine ring proton); 13C NMR: 
δ 99.7, 114.1, 127.3, 128.1, 129.1, 129.9, 132.4, 




[3,2 -a]-pyrimidine-6-carbonitrile, 4c: Yellow solid. 
Yield 64%. m.p.160ºC. IR: 3030 (C-H arom),  
2210 (C≡N streching), 1695 cm−1 (C=O of pyrimidine 
ring); 1H NMR (DMSO-d6): δ 8.30-8.06 (m, 4H, 
arom), 6.5(s,1H, pyrimidine ring proton); 13C NMR: δ 
99.6, 114.3, 124.3, 130.3, 136.9, 143.3, 150.0, 159.6, 
163.4, 168.3; MS: m/z (M+) 299.01 (100%). 
 
Conclusion 
In the present investigation, a series of new 
thiadiazolo pyrimidines have been synthesized in a 
single step by cycloelimination of the adduct formed 
by double aza- Michael addition. The synthesized 
compounds have been screened for their antifungal 
and antibacterial activity. The activity reveals that the 
synthesized compounds possess moderate to good 
activity profile. The insights gained from this study 
will be useful for development of new anti-infective 
agents. These reaction provides a high selective 
access to reaction sequences leading to the molecular 
motifs while combining structural, diversity, 
versatility and eco-compatibility. 
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